• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性间质性膀胱炎/膀胱疼痛综合征的临床表型分析:分类的关键,潜在改善管理。

Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management.

机构信息

Department of Urology, Queen's University at Kingston, Kingston, Ontario, Canada.

出版信息

J Urol. 2009 Jul;182(1):155-60. doi: 10.1016/j.juro.2009.02.122. Epub 2009 May 17.

DOI:10.1016/j.juro.2009.02.122
PMID:19447429
Abstract

PURPOSE

We have proposed a clinical phenotype system (UPOINT) to classify patients with urological pelvic pain to improve the understanding of etiology and guide therapy. We examined the relationship between UPOINT and symptoms in patients with interstitial cystitis/painful bladder syndrome.

MATERIALS AND METHODS

Patients with interstitial cystitis/painful bladder syndrome were classified in each domain of UPOINT, that is urinary, psychosocial, organ specific, infection, neurological/systemic and tenderness. Symptoms were assessed using the Interstitial Cystitis Symptom Index, Pain/Urgency/Frequency score and visual analogue scale for pain/urgency/frequency. Clinically relevant associations were calculated.

RESULTS

The mean age of 100 consecutive patients with interstitial cystitis/painful bladder syndrome was 48 years, median symptom duration was 7 years and median Interstitial Cystitis Symptom Index score was 12.8. The percent positive for each domain was urinary 100%, psychosocial 34%, organ specific 96%, infection 38%, neurological/systemic 45% and tenderness 48%. All patients were included in at least 2 domains, with 2 domains for 13%, 3 domains--35%, 4 domains--34%, 5 domains--13% and 6 domains--5%. The number of domains was associated with greater symptom duration (p = 0.014) but not age. The number of domains was also associated with poorer general interstitial cystitis and pain symptoms (Interstitial Cystitis Symptom Index p = 0.012, pain p = 0.036) but not with frequency or urgency. The psychosocial domain was associated with increased pain, urgency and frequency, while tenderness was associated with increased Interstitial Cystitis Symptom Index score, pain/urgency/frequency score and urgency. The neurological/systemic domain was associated with increased Interstitial Cystitis Symptom Index score while the infection domain was not associated with any increased symptoms.

CONCLUSIONS

The UPOINT phenotyping system can classify patients with interstitial cystitis according to clinically relevant domains. Increased symptom duration leads to a greater number of domains, and domains that function outside of the bladder (psychosocial, neurological, tenderness) predict a significant impact on symptoms. We hypothesize that the UPOINT system can direct multimodal therapy and improve outcomes.

摘要

目的

我们提出了一种临床表型系统(UPOINT),用于对泌尿外科盆腔疼痛患者进行分类,以提高对病因的认识并指导治疗。我们研究了 UPOINT 与间质性膀胱炎/膀胱疼痛综合征患者症状之间的关系。

材料和方法

将间质性膀胱炎/膀胱疼痛综合征患者归入 UPOINT 的每个领域,即泌尿系统、心理社会、器官特异性、感染、神经/系统性和压痛。使用间质性膀胱炎症状指数、疼痛/急迫/频率评分和疼痛/急迫/频率视觉模拟量表评估症状。计算临床相关关联。

结果

100 例连续间质性膀胱炎/膀胱疼痛综合征患者的平均年龄为 48 岁,中位症状持续时间为 7 年,中位间质性膀胱炎症状指数评分为 12.8。每个领域阳性的百分比为 100%泌尿系统、34%心理社会、96%器官特异性、38%感染、45%神经/系统性和 48%压痛。所有患者均至少归入 2 个领域,2 个领域占 13%,3 个领域占 35%,4 个领域占 34%,5 个领域占 13%,6 个领域占 5%。领域数量与更长的症状持续时间相关(p=0.014),但与年龄无关。领域数量也与更差的一般间质性膀胱炎和疼痛症状相关(间质性膀胱炎症状指数 p=0.012,疼痛 p=0.036),但与频率或急迫性无关。心理社会领域与疼痛、急迫性和频率增加相关,而压痛与间质性膀胱炎症状指数评分、疼痛/急迫性/频率评分和急迫性增加相关。神经/系统性领域与间质性膀胱炎症状指数评分增加相关,而感染领域与任何症状增加均无关。

结论

UPOINT 表型系统可根据临床相关领域对间质性膀胱炎患者进行分类。症状持续时间的延长导致更多的领域,而膀胱外(心理社会、神经、压痛)功能的领域预测对症状有显著影响。我们假设 UPOINT 系统可以指导多模式治疗并改善结局。

相似文献

1
Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management.女性间质性膀胱炎/膀胱疼痛综合征的临床表型分析:分类的关键,潜在改善管理。
J Urol. 2009 Jul;182(1):155-60. doi: 10.1016/j.juro.2009.02.122. Epub 2009 May 17.
2
Differences in the clinical presentation of interstitial cystitis/painful bladder syndrome in patients with or without sexual abuse history.有或无性虐待史的间质性膀胱炎/膀胱疼痛综合征患者临床表现的差异。
J Urol. 2008 Nov;180(5):2029-33. doi: 10.1016/j.juro.2008.07.053. Epub 2008 Sep 18.
3
Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity.慢性前列腺炎/慢性盆腔疼痛综合征患者的临床表型分析及其与症状严重程度的相关性
Urology. 2009 Mar;73(3):538-42; discussion 542-3. doi: 10.1016/j.urology.2008.09.074. Epub 2009 Jan 1.
4
Adding a sexual dysfunction domain to UPOINT system improves association with symptoms in women with interstitial cystitis and bladder pain syndrome.在UPOINT系统中添加性功能障碍领域可改善与间质性膀胱炎和膀胱疼痛综合征女性症状的相关性。
Urology. 2014 Dec;84(6):1308-13. doi: 10.1016/j.urology.2014.08.018. Epub 2014 Oct 12.
5
Improving the utility of clinical phenotyping in interstitial cystitis/painful bladder syndrome: from UPOINT to INPUT.提高间质性膀胱炎/膀胱疼痛综合征临床表型分析的效用:从UPOINT到INPUT
Can J Urol. 2018 Apr;25(2):9250-9254.
6
Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.基于表型的多模态治疗慢性前列腺炎/慢性盆腔疼痛综合征:一项使用 UPOINT 的前瞻性研究。
Urology. 2010 Jun;75(6):1249-53. doi: 10.1016/j.urology.2010.01.021. Epub 2010 Apr 3.
7
Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome.间质性膀胱炎/膀胱疼痛综合征及相关病症,重点介绍肠易激综合征、纤维肌痛和慢性疲劳综合征。
J Urol. 2010 Oct;184(4):1358-63. doi: 10.1016/j.juro.2010.06.005. Epub 2010 Aug 17.
8
Symptom profile variability of interstitial cystitis/painful bladder syndrome by age.间质性膀胱炎/膀胱疼痛综合征的症状谱随年龄变化的特征。
BJU Int. 2012 May;109(9):1356-9. doi: 10.1111/j.1464-410X.2011.10481.x. Epub 2011 Aug 24.
9
Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis.性功能是治疗难治性间质性膀胱炎女性生活质量低下的一个决定因素。
J Urol. 2007 May;177(5):1832-6. doi: 10.1016/j.juro.2007.01.060.
10
Sites of pain from interstitial cystitis/painful bladder syndrome.间质性膀胱炎/膀胱疼痛综合征的疼痛部位。
J Urol. 2008 Oct;180(4):1373-7. doi: 10.1016/j.juro.2008.06.039. Epub 2008 Aug 15.

引用本文的文献

1
Patient Related Outcomes for Interstitial Cystitis/Bladder Pain Syndrome Recommendations for Clinical Trials and General Urology Practice.间质性膀胱炎/膀胱疼痛综合征的患者相关结局:临床试验和普通泌尿外科实践的建议
Neurourol Urodyn. 2025 Sep;44(7):1455-1465. doi: 10.1002/nau.70107. Epub 2025 Jul 7.
2
Evaluation of clinical efficacy of pelvic ultrasound monitoring combined with scale scoring in the treatment of interstitial cystitis by intravesical instillation regimen combined with hydrodistention and transurethral fulguration.盆腔超声监测联合量表评分在膀胱水扩张联合经尿道电灼术膀胱灌注方案治疗间质性膀胱炎中的临床疗效评估
BMC Urol. 2025 May 7;25(1):117. doi: 10.1186/s12894-025-01764-0.
3
Applying K-Means Cluster Analysis to Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome: A New Perspective on Disease Classification.
将K均值聚类分析应用于间质性膀胱炎/膀胱疼痛综合征的尿液生物标志物:疾病分类的新视角
Int J Mol Sci. 2025 Apr 14;26(8):3712. doi: 10.3390/ijms26083712.
4
2025 Canadian Urological Association Guideline: Selected treatment recommendations for interstitial cystitis/bladder pain syndrome.《2025年加拿大泌尿外科协会指南:间质性膀胱炎/膀胱疼痛综合征的选定治疗建议》
Can Urol Assoc J. 2025 Apr;19(4):90-103. doi: 10.5489/cuaj.9182.
5
Evaluation of outcomes of clinical phenotyping-based treatment for bladder pain syndrome/interstitial cystitis.基于临床表型的膀胱疼痛综合征/间质性膀胱炎治疗效果评估。
Bladder (San Franc). 2024 Aug 23;11(1):e21200004. doi: 10.14440/bladder.2024.0010. eCollection 2024.
6
Secondary Analysis of Interstitial Cystitis/Bladder Pain Syndrome Patients Enrolled in a Recurrent Urinary Tract Infection Prevention Study Provides a Novel Paradigm for Etio-Pathogenesis and Practical Management of This Infection Phenotype.对参与复发性尿路感染预防研究的间质性膀胱炎/膀胱疼痛综合征患者进行的二次分析为这种感染表型的病因发病机制和实际管理提供了一种新的范例。
Pathogens. 2024 May 9;13(5):396. doi: 10.3390/pathogens13050396.
7
Urine biomarker could be a useful tool for differential diagnosis of a lower urinary tract dysfunction.尿液生物标志物可能是下尿路功能障碍鉴别诊断的一种有用工具。
Tzu Chi Med J. 2023 Dec 13;36(2):110-119. doi: 10.4103/tcmj.tcmj_221_23. eCollection 2024 Apr-Jun.
8
Validation of Distinct Bladder Pain Phenotypes Utilizing the MAPP Research Network Cohort.利用 MAPP 研究网络队列验证不同的膀胱疼痛表型。
Int Urogynecol J. 2024 Mar;35(3):637-648. doi: 10.1007/s00192-024-05735-1. Epub 2024 Feb 1.
9
Lower Urinary Tract Inflammation and Infection: Key Microbiological and Immunological Aspects.下尿路炎症与感染:关键的微生物学和免疫学方面
J Clin Med. 2024 Jan 5;13(2):315. doi: 10.3390/jcm13020315.
10
The Burden of Urinary Tract Infections on Quality of Life and Healthcare in Patients with Interstitial Cystitis.间质性膀胱炎患者中尿路感染对生活质量和医疗保健的负担
Healthcare (Basel). 2023 Oct 18;11(20):2761. doi: 10.3390/healthcare11202761.